functional medicine near me

ADC Therapeutics SA (ADCT) Q4 2022 Earnings Call Transcript | Seeking Alpha ADC Therapeutics SA (NYSE:ADCT) Q4 2022 Results Conference Call February 28, 2023 8:30 AM ET Company Participants Amanda Hamilton - IR Manager Ameet Mallik - CEO Kristen Harrington-Smith - Chief Commercial Officer Mohamed Zaki - Chief Medical Officer Pepe Carmona - Chief Financial Officer Conference Call Participants Kelly Shi - Jefferies Sudan N. Loganathan - RBC Naureen Quibria - Capital One Securities Brian Cheng - JPMorgan Operator Welcome to the ADC Therapeutics Fourth Quarter and Full Year 2022 Financial Results Conference Call. My name is Andrew, and I'll be your operator for today's call. At this time, all participants are in listen-only mode. Later, we will conduct a question-and-answer session. [Operator Instructions] I will now turn the call over to Amanda Loshbaugh, Investor Relations Manager. Amanda, you may begin. Amanda Hamilton Thank you, operator. This morning, we issued a press release...

3D-printed organs may soon be a reality | Fortune Well Last year, in San Antonio, Texas, Dr. Arturo Bonilla carefully implanted an outer ear on a 20-year-old woman born without one. The ear on the woman’s right side, had been constructed in the size and shape of her left. For Bonilla, a pediatric microtia surgeon (a doctor who treats birth defects of the ear) for more than 25 years and a recognized expert in the field, such a procedure would normally be routine. But this case had a twist: For the first time, the ear he was implanting was the product of a 3D bioprinter using the woman’s own cartilage cells. The implant procedure, Bonilla told me, was “very uneventful.” It is a vast understatement, all things considered. From the realm of near-fiction to the germ of an idea to actual science, 3D bioprinting is advancing across all aspects of medical research—and, now, practice. The pace is slow, and target dates for some of the most ambitious 3D plans are decades off. But progress is rea...